HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

(1S,4S,4aR,5R,8R,8aS)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene

HCID 61103
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

Standard SMILES
ClC1=C(Cl)[C@@]2(Cl)[C@H]3[C@H]([C@H]4C=C[C@H]3C4)[C@@]1(Cl)C2(Cl)Cl
InChIKey
QBYJBZPUGVGKQQ-VFBQXPTHSA-N
Molecular formula
C12H8Cl6
Average molar mass
364.9 g/mol
Monoisotopic mass
361.875716

Overview

Aldrin can cause cancer according to an independent committee of scientific and health experts.

Names & identifiers

Preferred name
(1S,4S,4aR,5R,8R,8aS)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene
IUPAC
(1S,2S,3R,6R,7R,8S)-1,8,9,10,11,11-hexachlorotetracyclo[6.2.1.13,6.02,7]dodeca-4,9-diene

Names & synonyms

DTXSID10947432(1s,4s,4ar,5r,8r,8as)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthaleneRefChem:1049532DTXCID201375690C07552SCHEMBL28042673

Database identifiers

PubChem CID
61103
DTXSID
DTXSID10947432

Properties

Computed structural properties

XLogP
4.5
Topological polar surface area
0 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
0
Rotatable bonds
0
Heavy atoms
18
Formal charge
0
Complexity
481

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety & protection

Minimum Risk LevelAcute Oral: 0.002 mg/kg/day (L134) Chronic Oral: 0.00003 mg/kg/day (L134)

Toxicology

TreatmentTreatment is symptomatic, aimed at controlling convulsions, coma, and respiratory depression. If ingested, gastric lavage may be performed, followed by administering activated charcoal powder. (L145)
Health Effects · 1 item

Aldrin is a neurotoxin and works by overstimulating the central nervous system. Ingestion of large amounts of aldrin causes convulsions and death. However, chronic exposure to lower amounts of aldrin also has adverse affects because it is oxidized to dieldrin, which accumulates in the body. Dieldrin is known to damage the nervous system, liver, and immune system. (L87)

Exposure RoutesOral (L87) ; inhalation (L87) ; dermal (L87)
Toxicity Summary · 1 item

Aldrin antagonizes the action of the neurotransmitter gamma-aminobutyric acid (GABA) acting at the GABA-A receptors, effectively blocking the GABA-induced uptake of chloride ions. Aldrin also inhibits Na+ K+ ATPase and Ca2+ and Mg2+ ATPase which are essential for the transport of calcium across membranes. This results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the CNS. This results in hyperexcitation and generalized seizures. (T10, L87)

Signs and SymptomsExposure to aldrin results in headaches, dizziness, irritability, nausea and vomiting, cardiac arrhythmias, muscular weakness, uncontrolled muscle movements, hyperexcitability, seizures and coma. (L87)

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

Aldrin is absorbed throught the gastrointestinal tract, lungs and skin. Following absorption, aldrin is redistributed primarily to fat via the lymphatic system. Once in the body, aldrin is readily converted to dieldrin, primarily in the liver by mixed-function oxidases of the cytochrome P-450 system, and to a lesser extent in the lung and skin. Aldrin may also be epoxidized to dieldrin by a prostaglandin synthetase-mediated pathway inextrahepatic tissues. Dieldrin is metabolized by liver microsomal monooxygenases and epoxide hydratases. Its metabolites, of which the primary one is 9-hydroxydieldrin, are excreted in the faeces. (L87)

Uses & manufacturing

UsesAldrin is used as an insecticide. (L144)

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
Carcinogen Classification
3, not classifiable as to its carcinogenicity to humans. (L135)
Toxicity DataLD50: 39 mg/kg (Oral, Rat) (T18) LD50: 98 mg/kg (Dermal, Rat) (T18) LD50: 150 mg/kg (Intraperitoneal, Rat) (T17) LD50: 21 mg/kg (Intravenous, Mouse) (T17)